U.S., Jan. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07368530) titled 'Using Machine Learning to Identify Responders to TACE or HAIC for uHCC' on Jan. 16.
Brief Summary: The goal of this observational study is to learn about the efficacy of Transarterial Chemoembolization (TACE) versus Hepatic Arterial Infusion Chemotherapy (HAIC) in patients with unresectable hepatocellular carcinoma (HCC). The main questions it aims to answer are:
Can distinct imaging phenotype subtypes be identified in unresectable HCC patients using radiomics and unsupervised clustering?
Do these different imaging subtypes show significant differences in treatment efficacy (such as objective response rate, progression-free surviv...